TScan Therapeutics, Inc (TCRX) – FDA
-
TScan Therapeutics (TCRX) Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101
-
TScan Therapeutics, Inc (TCRX) Announces FDA Clearance of Investigational NDA for TSC-203-A0201
-
-
-
-
-
-
-
Back to TCRX Stock Lookup